AAAAAA

   
Results: 1-10 |
Results: 10
POLY(LACTIC-GLYCOLIC) ACID COPOLYMER ENCAPSULATION OF RECOMBINANT ADENOVIRUS REDUCES IMMUNOGENICITY IN-VIVO
Authors: BEER SJ MATTHEWS CB STEIN CS ROSS BD HILFINGER JM DAVIDSON BL
Citation: Sj. Beer et al., POLY(LACTIC-GLYCOLIC) ACID COPOLYMER ENCAPSULATION OF RECOMBINANT ADENOVIRUS REDUCES IMMUNOGENICITY IN-VIVO, Gene therapy, 5(6), 1998, pp. 740-746
OVEREXPRESSION OF HUMAN INTESTINAL OLIGOPEPTIDE TRANSPORTER IN MAMMALIAN-CELLS VIA ADENOVIRAL TRANSDUCTION
Authors: HSU CP HILFINGER JM WALTER E MERKLE HP ROESSLER BJ AMIDON GL
Citation: Cp. Hsu et al., OVEREXPRESSION OF HUMAN INTESTINAL OLIGOPEPTIDE TRANSPORTER IN MAMMALIAN-CELLS VIA ADENOVIRAL TRANSDUCTION, Pharmaceutical research, 15(9), 1998, pp. 1376-1381
EXTENDED-RELEASE OF ADENOVIRUS FROM POLYMER MICROSPHERES - POTENTIAL USE IN GENE-THERAPY FOR BRAIN-TUMORS
Authors: BEER SJ HILFINGER JM DAVIDSON BL
Citation: Sj. Beer et al., EXTENDED-RELEASE OF ADENOVIRUS FROM POLYMER MICROSPHERES - POTENTIAL USE IN GENE-THERAPY FOR BRAIN-TUMORS, Advanced drug delivery reviews, 27(1), 1997, pp. 59-66
ADENOVIRUS-MEDIATED GENE-TRANSFER TO INTESTINAL EPITHELIAL-CELLS AS APOTENTIAL APPROACH FOR ORAL DELIVERY OF PEPTIDES AND PROTEINS
Authors: WALTER E CROYLE MA DAVIDSON BL ROESSLER BJ HILFINGER JM AMIDON GL
Citation: E. Walter et al., ADENOVIRUS-MEDIATED GENE-TRANSFER TO INTESTINAL EPITHELIAL-CELLS AS APOTENTIAL APPROACH FOR ORAL DELIVERY OF PEPTIDES AND PROTEINS, Journal of controlled release, 46(1-2), 1997, pp. 75-87
THE SEQUENCE AND STRUCTURE OF THE 3'-ARM OF THE FIRST STEM-LOOP OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-3 TRANSACTIVATION RESPONSIVE REGION MEDIATE TAT-2 TRANSACTIVATION
Authors: BROWNING C HILFINGER JM RAINIER S LIN V HEDDERWICK S SMITH M MARKOVITZ DM
Citation: C. Browning et al., THE SEQUENCE AND STRUCTURE OF THE 3'-ARM OF THE FIRST STEM-LOOP OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-3 TRANSACTIVATION RESPONSIVE REGION MEDIATE TAT-2 TRANSACTIVATION, Journal of virology, 71(10), 1997, pp. 8048-8055
ORAL ADENOVIRUS FOR TREATMENT OF INFLAMMATORY BOWEL-DISEASE
Authors: HILFINGER JM ZIMMERMANN EM ROESSLER BJ AMIDON GL
Citation: Jm. Hilfinger et al., ORAL ADENOVIRUS FOR TREATMENT OF INFLAMMATORY BOWEL-DISEASE, Gastroenterology, 112(4), 1997, pp. 995-995
HT29-MTX CACO-2 COCULTURES AS AN IN-VITRO MODEL FOR THE INTESTINAL EPITHELIUM - IN-VITRO IN-VIVO CORRELATION WITH PERMEABILITY DATA FROM RATS AND HUMANS/
Authors: WALTER E JANICH S ROESSLER BJ HILFINGER JM AMIDON GL
Citation: E. Walter et al., HT29-MTX CACO-2 COCULTURES AS AN IN-VITRO MODEL FOR THE INTESTINAL EPITHELIUM - IN-VITRO IN-VIVO CORRELATION WITH PERMEABILITY DATA FROM RATS AND HUMANS/, Journal of pharmaceutical sciences, 85(10), 1996, pp. 1070-1076
BACTERIOPHAGE-T4 RIBONUCLEOSIDE DIPHOSPHATE REDUCTASE - ON THE DEFECTCAUSING DECREASED FORMATION OF THE BETA(93)(2) SUBUNIT ENCODED BY THENRDB93 MUTANT-GENE
Authors: HILFINGER JM HE P
Citation: Jm. Hilfinger et P. He, BACTERIOPHAGE-T4 RIBONUCLEOSIDE DIPHOSPHATE REDUCTASE - ON THE DEFECTCAUSING DECREASED FORMATION OF THE BETA(93)(2) SUBUNIT ENCODED BY THENRDB93 MUTANT-GENE, Gene, 142(1), 1994, pp. 55-60
ACTIVATION OF THE HUMAN T-CELL LEUKEMIA-VIRUS TYPE-I ENHANCER IS MEDIATED BY BINDING-SITES FOR ELF-1 AND THE PETS FACTOR
Authors: CLARK NM SMITH MJ HILFINGER JM MARKOVITZ DM
Citation: Nm. Clark et al., ACTIVATION OF THE HUMAN T-CELL LEUKEMIA-VIRUS TYPE-I ENHANCER IS MEDIATED BY BINDING-SITES FOR ELF-1 AND THE PETS FACTOR, Journal of virology, 67(9), 1993, pp. 5522-5528
DIFFERENTIAL REGULATION OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-2 ENHANCER IN MONOCYTES AT VARIOUS STAGES OF DIFFERENTIATION
Authors: HILFINGER JM CLARK N SMITH M ROBINSON K MARKOVITZ DM
Citation: Jm. Hilfinger et al., DIFFERENTIAL REGULATION OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-2 ENHANCER IN MONOCYTES AT VARIOUS STAGES OF DIFFERENTIATION, Journal of virology, 67(7), 1993, pp. 4448-4453
Risultati: 1-10 |